AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22306121 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab untreated (n=63)
Number of subjects: 853
Study 19921204 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction setting A (1 mm section thickness, soft kernel)
Number of subjects: 200
Study 19921204 — intervention group
Group type: COMPARATOR
Intervention: Reconstruction setting B (2 mm section thickness, soft kernel)
Number of subjects: 200
Study 19921204 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstruction setting C (2 mm section thickness, sharp kernel)
Number of subjects: 200
Study 19921204 — intervention group
Group type: COMPARATOR
Intervention: Comparison of settings A and C to setting B
Number of subjects: 200
Study 19066233 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking routes (n = 19)
Number of subjects: 70
Study 19066233 — intervention group
Group type: EXPERIMENTAL
Intervention: Walking while working (n = 25)
Number of subjects: 70
Study 19066233 — intervention group
Group type: EXPERIMENTAL
Intervention: Both walking interventions pooled (n = 44)
Number of subjects: 70
Study 19066233 — intervention group
Group type: EXPERIMENTAL
Intervention: Active group (> 10,000 steps/day, n = 21)
Number of subjects: 70
Study 19066233 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately Active group (7500-9999, n = 11)
Number of subjects: 70
Study 19066233 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary-Low activity group
Number of subjects: 70
Study 19066233 — intervention group
Group type: EXPERIMENTAL
Intervention: Initially low active participants
Number of subjects: 70
Study 18190629 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable dosage of sildenafil (25, 50, 100 mg) or vardenafil (5, 10, 20 mg) determined by NPTR
Number of subjects: 154
Study 18190629 — intervention group
Group type: COMPARATOR
Intervention: Fixed low-dose sildenafil 25 mg or vardenafil 5 mg
Number of subjects: 154
Study 18190629 — intervention group
Group type: EXPERIMENTAL
Intervention: Variable dosage of sildenafil or vardenafil
Number of subjects: 154
Study 18190629 — intervention group
Group type: COMPARATOR
Intervention: Fixed low-dose sildenafil or vardenafil
Number of subjects: 154
Study 14748034 — intervention group
Group type: EXPERIMENTAL
Intervention: gamma frailty model
Number of subjects: 0
Study 11305719 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncatheter-related thrombosis in children with underlying disorders
Number of subjects: 95
Study 9165187 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (low-saturated-fat, low-cholesterol, high-carbohydrate diet)
Number of subjects: 148
Study 9165187 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard diet)
Number of subjects: 148
Study 9165187 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention fathers
Number of subjects: 148
Study 9165187 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention mothers
Number of subjects: 148
Study 9165187 — intervention group
Group type: COMPARATOR
Intervention: Control parents
Number of subjects: 148
Study 7659137 — intervention group
Group type: EXPERIMENTAL
Intervention: Flutrimazole 1% dermal cream
Number of subjects: 484
Study 7659137 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole 1% dermal cream
Number of subjects: 484
Study 3499502 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulbactam and ampicillin (SA)
Number of subjects: 100
Study 3499502 — intervention group
Group type: COMPARATOR
Intervention: Metronidazole and cefotaxime (MC)
Number of subjects: 100
Study 30890314 — intervention group
Group type: EXPERIMENTAL
Intervention: Bidirectional knotless barbed suture (group A)
Number of subjects: 70
Study 30890314 — intervention group
Group type: COMPARATOR
Intervention: Polyglactin suture (group B)
Number of subjects: 70
Study 30890314 — intervention group
Group type: EXPERIMENTAL
Intervention: Total surgery time (both groups)
Number of subjects: 70
Study 30280800 — intervention group
Group type: EXPERIMENTAL
Intervention: TA + TNR
Number of subjects: 4
Study 30280800 — intervention group
Group type: COMPARATOR
Intervention: TA ‐ TNR
Number of subjects: 4
Study 30280800 — intervention group
Group type: EXPERIMENTAL
Intervention: TA + TR
Number of subjects: 4
Study 30280800 — intervention group
Group type: COMPARATOR
Intervention: TA ‐ TR
Number of subjects: 4
Study 26888731 — intervention group
Group type: EXPERIMENTAL
Intervention: Allogeneic-adipose-derived mesenchymal stem cells (ALLO-ASCs) injected into the anal sphincter (doses: 3 × 10(7), 6 × 10(7), 9 × 10(7) cells)
Number of subjects: 0
Study 26888731 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline injection mixed with fibrin glue (placebo)
Number of subjects: 0
Study 25075802 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT) delivered by a child anxiety specialist in the primary care clinic
Number of subjects: 48
Study 25075802 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-supported bibliotherapy (implemented by the parent with therapist support by telephone)
Number of subjects: 48
Study 25075802 — intervention group
Group type: COMPARATOR
Intervention: Both modalities (CBT and therapist-supported bibliotherapy)
Number of subjects: 48
Study 23101118 — intervention group
Group type: EXPERIMENTAL
Intervention: Tight glucose control (TGC)
Number of subjects: 569
Study 23101118 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 569
Study 20586997 — intervention group
Group type: EXPERIMENTAL
Intervention: Preterm adolescents
Number of subjects: 391
Study 20586997 — intervention group
Group type: COMPARATOR
Intervention: Term controls
Number of subjects: 391
Study 17096196 — intervention group
Group type: EXPERIMENTAL
Intervention: SAMHSA Model Program keepin' it REAL (prevention program)
Number of subjects: 1364
Study 15754236 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic practice muscle strengthening program (TG1)
Number of subjects: 102
Study 15754236 — intervention group
Group type: EXPERIMENTAL
Intervention: Health club muscle strengthening program (TG2)
Number of subjects: 102
Study 15754236 — intervention group
Group type: EXPERIMENTAL
Intervention: Gymnastic group muscle strengthening program (TG3)
Number of subjects: 102
Study 15754236 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 102
Study 12047050 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual presentation of verbal material in serial recall tasks
Number of subjects: 0
Study 12047050 — intervention group
Group type: COMPARATOR
Intervention: Auditory presentation of verbal material in serial recall tasks
Number of subjects: 0
Study 10452168 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental bone lesions created in the alveolar crest of a skull, assessed using standardized periapical radiographs before and after defect creation.
Number of subjects: 5
Study 10452168 — intervention group
Group type: COMPARATOR
Intervention: Standardized periapical radiographs obtained before and after the defects were made.
Number of subjects: 5
Study 7615189 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine (1.5 g twice a day)
Number of subjects: 163
Study 7615189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 163
Study 2565158 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol
Number of subjects: 21
Study 2565158 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevantolol combined with hydrochlorothiazide
Number of subjects: 21
Study 2565158 — intervention group
Group type: COMPARATOR
Intervention: Hydrochlorothiazide
Number of subjects: 21
Study 823950 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyrotropin releasing hormone (TRH)
Number of subjects: 0
Study 823950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30321962 — intervention group
Group type: EXPERIMENTAL
Intervention: Scarf osteotomy
Number of subjects: 48
Study 30321962 — intervention group
Group type: COMPARATOR
Intervention: Long chevron osteotomy
Number of subjects: 48
Study 28949074 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey + high-MCFAs
Number of subjects: 52
Study 28949074 — intervention group
Group type: EXPERIMENTAL
Intervention: High-MCFAs (independently of protein type)
Number of subjects: 52
Study 25989154 — intervention group
Group type: EXPERIMENTAL
Intervention: TEAS (transcutaneous electric acupoint stimulation) group (n=31)
Number of subjects: 63
Study 25989154 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=32)
Number of subjects: 63
Study 23815739 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART Arm training with OT-stim and usual therapy
Number of subjects: 75
Study 23815739 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART Arm training without OT-stim and usual therapy
Number of subjects: 75
Study 23815739 — intervention group
Group type: COMPARATOR
Intervention: Usual therapy alone
Number of subjects: 75
Study 21084162 — intervention group
Group type: EXPERIMENTAL
Intervention: Paresthesic SCS (group PS; n=10)
Number of subjects: 25
Study 21084162 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal SCS (group SS; n=7)
Number of subjects: 25
Study 21084162 — intervention group
Group type: COMPARATOR
Intervention: Sham SCS (group NS; n=8)
Number of subjects: 25
Study 21084162 — intervention group
Group type: EXPERIMENTAL
Intervention: Paresthesic SCS (group PS)
Number of subjects: 25
Study 21084162 — intervention group
Group type: EXPERIMENTAL
Intervention: Subliminal SCS (group SS)
Number of subjects: 25
Study 18931330 — intervention group
Group type: EXPERIMENTAL
Intervention: FeNO0.05 plus symptom monitoring
Number of subjects: 151
Study 18931330 — intervention group
Group type: COMPARATOR
Intervention: Monitoring of symptoms only
Number of subjects: 151
Study 17332127 — intervention group
Group type: EXPERIMENTAL
Intervention: Vastus-splitting approach
Number of subjects: 42
Study 17332127 — intervention group
Group type: COMPARATOR
Intervention: Median parapatellar approach
Number of subjects: 42
Study 15121746 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride (NaCl) as the iontophoresis vehicle for ACh
Number of subjects: 14
Study 15121746 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium chloride (NaCl) as the iontophoresis vehicle for SNP
Number of subjects: 14
Study 15121746 — intervention group
Group type: COMPARATOR
Intervention: Deionized water as the iontophoresis vehicle for ACh
Number of subjects: 14
Study 15121746 — intervention group
Group type: COMPARATOR
Intervention: Deionized water as the iontophoresis vehicle for SNP
Number of subjects: 14
Study 14991292 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted balance training
Number of subjects: 24
Study 14991292 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise program
Number of subjects: 24
Study 11757182 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved-field radiotherapy (IF-RT)
Number of subjects: 47
Study 11757182 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-field radiotherapy (EF-RT)
Number of subjects: 47
Study 11757182 — intervention group
Group type: EXPERIMENTAL
Intervention: Total lymphatic irradiation (TLI)
Number of subjects: 47
Study 11757182 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy doses of 26-34 Gy
Number of subjects: 47
Study 11757182 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy doses of 36 Gy
Number of subjects: 47
Study 11757182 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy doses of 40 Gy or more
Number of subjects: 47
Study 9221383 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleomycin (BMC)
Number of subjects: 102
Study 9221383 — intervention group
Group type: COMPARATOR
Intervention: Mitoxantrone (MIT)
Number of subjects: 102
Study 8214404 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 76
Study 8214404 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 76
Study 8214404 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 76
Study 3039831 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone (N) + Dexamethasone (DXM)
Number of subjects: 40
Study 3039831 — intervention group
Group type: COMPARATOR
Intervention: Nabilone (N) alone
Number of subjects: 40
Study 28734971 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic system
Number of subjects: 36
Study 28734971 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic approach
Number of subjects: 36
Study 26374339 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 0
Study 26374339 — intervention group
Group type: COMPARATOR
Intervention: Bag-Mask Ventilation (BMV)
Number of subjects: 0
Study 25794092 — intervention group
Group type: EXPERIMENTAL
Intervention: Simethicone (200 mg)
Number of subjects: 80
Study 25794092 — intervention group
Group type: COMPARATOR
Intervention: Control (no simethicone)
Number of subjects: 80
Study 23926275 — intervention group
Group type: EXPERIMENTAL
Intervention: Disruption of dorsolateral prefrontal cortex (DLPFC) function
Number of subjects: 0
Study 23926275 — intervention group
Group type: EXPERIMENTAL
Intervention: Disruption of ventrolateral prefrontal cortex (VLPFC) function
Number of subjects: 0
Study 21147298 — intervention group
Group type: EXPERIMENTAL
Intervention: Low concentration (LC) contrast medium (150 mg iodine/ml)
Number of subjects: 95
Study 21147298 — intervention group
Group type: COMPARATOR
Intervention: High concentration (HC) contrast medium (300 mg iodine/ml)
Number of subjects: 95
Study 18942560 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual support in adjunct to written informative form
Number of subjects: 0
Study 18942560 — intervention group
Group type: COMPARATOR
Intervention: Written informative form only
Number of subjects: 0
Study 16141380 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart failure patients
Number of subjects: 9
Study 12701664 — intervention group
Group type: EXPERIMENTAL
Intervention: Errorless learning
Number of subjects: 54
Study 12701664 — intervention group
Group type: COMPARATOR
Intervention: Conventional trial-and-error instruction
Number of subjects: 54
Study 10949003 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate (C)
Number of subjects: 15
Study 10949003 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 15
Study 8839907 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin/5-fluorouracil concurrent with radiotherapy (group I)
Number of subjects: 74
Study 8839907 — intervention group
Group type: COMPARATOR
Intervention: Radiotherapy alone (historical control group II)
Number of subjects: 74
Study 1467206 — intervention group
Group type: EXPERIMENTAL
Intervention: Discrete scale (DS)
Number of subjects: 849
Study 1467206 — intervention group
Group type: COMPARATOR
Intervention: Visual analogue scale (VAS)
Number of subjects: 849
Study 1467206 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous chromatic analogue scale (ACCS)
Number of subjects: 849
Study 1467206 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantity (Q)
Number of subjects: 849
Study 1467206 — intervention group
Group type: EXPERIMENTAL
Intervention: Entity (E)
Number of subjects: 849
Study 1467206 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal Intensity (MI)
Number of subjects: 849
Study 6370157 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic administration of 4 units of platelet concentrates at the end of bypass
Number of subjects: 28
Study 6370157 — intervention group
Group type: COMPARATOR
Intervention: Control group (not receiving platelet concentrates)
Number of subjects: 28
Study 6370157 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic administration of platelet concentrates
Number of subjects: 28
Study 31481568 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic medication review intervention using the 'Systematic Tool to Reduce Inappropriate Prescribing'‐Assistant (STRIPA)
Number of subjects: 0
Study 31481568 — intervention group
Group type: COMPARATOR
Intervention: Standard care sham intervention (GP discusses medication list completeness)
Number of subjects: 0
Study 31481568 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic medication review intervention
Number of subjects: 0
Study 29489977 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF injection for 3 days after chemotherapy
Number of subjects: 100
Study 29489977 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 100
Study 26458034 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic glatiramer acetate (20 mg)
Number of subjects: 794
Study 26458034 — intervention group
Group type: EXPERIMENTAL
Intervention: Brand glatiramer acetate (20 mg)
Number of subjects: 794
Study 26458034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 794
Study 23842212 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon beta-1b (IFNB-1b)
Number of subjects: 468
Study 23842212 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 468
Study 22480437 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates based core stability training
Number of subjects: 0
Study 22480437 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised physiotherapy exercise
Number of subjects: 0
Study 22480437 — intervention group
Group type: COMPARATOR
Intervention: Contract-relax relaxation sessions (placebo control)
Number of subjects: 0
Study 19490266 — intervention group
Group type: EXPERIMENTAL
Intervention: VT induced by 1 or 2 VES or burst pacing (single VES n = 15, double VES n = 127, burst n = 7, total n = 149)
Number of subjects: 371
Study 19490266 — intervention group
Group type: COMPARATOR
Intervention: VT induced by 3 VES (n = 222)
Number of subjects: 371
Study 17516858 — intervention group
Group type: EXPERIMENTAL
Intervention: High-vegetable dietary intervention
Number of subjects: 1156
Study 17516858 — intervention group
Group type: COMPARATOR
Intervention: Comparison group
Number of subjects: 1156
Study 15161434 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine (Gemzar®) as a single agent
Number of subjects: 0
Study 15161434 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine in combination with platinum-based chemotherapy
Number of subjects: 0
Study 15161434 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine in combination with radiotherapy
Number of subjects: 0
Study 12075638 — intervention group
Group type: EXPERIMENTAL
Intervention: IV ephedrine infusion (5 mg.min(‐1) immediately after spinal injection)
Number of subjects: 30
Study 12075638 — intervention group
Group type: COMPARATOR
Intervention: Bolus administration of IV ephedrine (10 mg in case of hypotension)
Number of subjects: 30
Study 10458204 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel at 100 mg/m2 administered as a 1-hour intravenous infusion every 3 weeks
Number of subjects: 0
Study 10458204 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel at 100 mg/m2 or 75 mg/m2
Number of subjects: 0
Study 10458204 — intervention group
Group type: COMPARATOR
Intervention: Control regimen of vinorelbine or ifosfamide
Number of subjects: 0
Study 7802271 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative oxygen saturation monitoring in 19 children
Number of subjects: 69
Study 7802271 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative oxygen saturation monitoring in 50 children
Number of subjects: 69
Study 7802271 — intervention group
Group type: COMPARATOR
Intervention: Comparison of monitored time with oxygen saturation less than 95%, 90%, 85%, or 80%
Number of subjects: 69
Study 2180328 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants or placebo (3-6 weeks treatment)
Number of subjects: 112
Study 2180328 — intervention group
Group type: COMPARATOR
Intervention: Control subjects (normal subjects)
Number of subjects: 112
Study 380269 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxapine
Number of subjects: 48
Study 380269 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 48
Study 6345340 — intervention group
Group type: EXPERIMENTAL
Intervention: Activated charcoal (10 g)
Number of subjects: 48
Study 6345340 — intervention group
Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 48
Study 29475774 — intervention group
Group type: EXPERIMENTAL
Intervention: DAO enzyme supplementation
Number of subjects: 100
Study 29475774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 29703182 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning label with 'damages your health' (without 'can')
Number of subjects: 619
Study 29703182 — intervention group
Group type: EXPERIMENTAL
Intervention: Warning label with 'causes cancer'
Number of subjects: 619
Study 29703182 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving no warning label
Number of subjects: 619
Study 27322802 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy drinking confederate
Number of subjects: 0
Study 27322802 — intervention group
Group type: EXPERIMENTAL
Intervention: Light drinking confederate
Number of subjects: 0
Study 27322802 — intervention group
Group type: COMPARATOR
Intervention: No (alcohol) drinking confederate
Number of subjects: 0
Study 24875804 — intervention group
Group type: EXPERIMENTAL
Intervention: Short daily hemodialysis
Number of subjects: 0
Study 24875804 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis
Number of subjects: 0
Study 22959457 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular progesterone (IMP) 25-50 mg/d
Number of subjects: 738
Study 22959457 — intervention group
Group type: COMPARATOR
Intervention: 8% Crinone vaginal gel
Number of subjects: 738
Study 20492837 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS-MPH (titrated to 72 mg/d)
Number of subjects: 255
Study 20492837 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 20492837 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS-MPH
Number of subjects: 255
Study 18541000 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg twice-daily
Number of subjects: 520
Study 18541000 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 10 mg twice-daily
Number of subjects: 520
Study 18541000 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban 20 mg once-daily
Number of subjects: 520
Study 18541000 — intervention group
Group type: COMPARATOR
Intervention: LMWH followed by VKA
Number of subjects: 520
Study 18541000 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban (all groups combined)
Number of subjects: 520
Study 18541000 — intervention group
Group type: COMPARATOR
Intervention: LMWH/VKA (control group)
Number of subjects: 520
Study 14998812 — intervention group
Group type: EXPERIMENTAL
Intervention: Signs of Suicide (SOS) prevention program
Number of subjects: 2100